Literature DB >> 454231

Regional cerebral blood flow in patients with Parkinson's disease.

S Lavy, E Melamed, G Cooper, S Bentin, Y Rinot.   

Abstract

Regional cerebral blood flow (rCBF) was measured by the xenon 133 inhalation method in 60 patients with Parkinson's disease and compared with flow data obtained in 51 age-matched normal control subjects. Mean brain rCBF was significantly reduced in patients with parkinsonism (9.5%, P less than .001). The most marked and significant rCBF decreases were observed in the older patients (18.8%, P less than .001). There was no correlation between degree of rCBF reduction and duration of parkinsonism. Decreases in hemispheric mean rCBF values were similar in both hemispheres even in patients with unilateral signs. The present study provides additional evidence for involvement of the cerebral cortex in Parkinson's disease. The rCBF decline may be associated in part with high prevalence of mental impairment and cortical atrophy and with diminished cerebral metabolic rate due to brain dopamine deficiency in patients with parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 454231     DOI: 10.1001/archneur.1979.00500420054005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow.

Authors:  Sina Aslan; Hanzhang Lu
Journal:  Magn Reson Imaging       Date:  2010-04-27       Impact factor: 2.546

2.  Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations.

Authors:  E Melamed; M Globus; B Mildworf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

3.  Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.

Authors:  R G Brown; C D Marsden; N Quinn; M A Wyke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

4.  Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.

Authors:  S J Wang; R S Liu; H C Liu; K N Lin; D E Shan; K K Liao; J L Fuh; L S Lee
Journal:  Eur J Nucl Med       Date:  1993-04

5.  Evoked potentials and cerebral blood flow in solvent induced psycho-organic syndrome.

Authors:  D Deschamps; R Garnier; F Lille; Y Tran Dinh; L Bertaux; A Reygagne; S Dally
Journal:  Br J Ind Med       Date:  1993-04

6.  Features of brain atrophy in Parkinson's disease. A CT scan study.

Authors:  I Steiner; J M Gomori; E Melamed
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

7.  Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

Authors:  D Rougemont; J C Baron; P Collard; P Bustany; D Comar; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.